News search

E.g., 22/11/2024
E.g., 22/11/2024
María J. Andrés-Manzano, Pilar Gonzalo, Rosa M. Carmona, Cristina González-Gómez, Ana Barettino, Ignacio Benedicto, Vicente Andrés and Ana Dopazo.
Research
7 Oct 2024

A team of scientists from the CNIC and the CSIC has identified a key mechanism in the development of atherosclerosis in patients with the rare genetic disease Hutchinson-Gilford progeria syndrome

image
Research
9 Sep 2024

The new study, published in the journal Circulation, opens a new avenue of research into treatments for the atherosclerosis associated with progeria

Alexandra y Xoel
María Jesús Andrés, Carla Espinós (detrás), Rosa M Nevado (delante, al lado de MJA), Miguel de la Fuente, Rosa Carmona, Ana Barettino, Vicente Andrés, Pilar Gonzalo e Ignacio Benedicto.
Research
19 Apr 2024

The elimination of progerin from vascular smooth muscle cells, but not from endothelial cells, prevents the atherosclerosis associated with Hutchinson-Gilford progeria syndrome (HGPS)

About the CNIC
29 Feb 2024
Alexandra
Álvaro Macías, Jesús Vázquez, Pilar Gonzalo, Carla Espinós, Beatriz Dorado, Emilio Camafeita, Vicente Andrés, María J Andrés, Cristina González, Amanda Sánchez, Víctor Fanjul.
Research
26 Oct 2021

Scientists from the CNIC and the CIBERCV have generated the first experimental animal model that develops Hutchinson-Gilford Progeria Syndrome and allows its controlled reversal


Pilar Gonzalo, Rosa Nevado, Ricardo Villa-Bellosta, Magda R. Hamczyk, María J. Andrés-Manzano, and Vicente Andrés.
Research
12 Mar 2019

This new results, published in EMBO Molecular Medicine, identify a possible therapeutic target for this genetic disease

Foto
Research
5 Mar 2018

Investigadores del CNIC, del CIBERCV y de la Universidad de Oviedo han creado el primer modelo de ratón con aterosclerosis acelerada por la proteína progerina